Diabetes · Adults with mental disorders in low‐ and middle‐income countries
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drop‐out Objective · Adults with mental disorders in low‐ and middle‐income countries
It is very uncertain whether SSRI antidepressants changes drop‐outs (12 weeks) compared with TCA (very low certainty).
1 finding from 1 review
Fasting blood glucose (mg/dL) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Body‐mass index (BMI) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Outcomes (2‐6 months post‐treatment) · adults with panic disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
Selective serotonin reuptake inhibitors may leads to lower failure to respond compared with placebo (low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
Selective serotonin reuptake inhibitors showed no clear difference in total number of dropouts compared with placebo (moderate certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
Selective serotonin reuptake inhibitors probably leads to lower failure to remit compared with placebo (moderate certainty).
1 finding from 1 review
panic symptoms · adults with panic disorder
2 findings from 1 review
Withdrawals due to adverse events · adults with panic disorder
Selective serotonin reuptake inhibitors probably leads to higher number of dropouts due to adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
Subjective sleep quality or quantity · adults with insomnia
1 finding from 1 review
Other subjective measures of sleep (total sleep time, sleep onset latency, nocturnal awakenings and subjective sleep efficiency) (PSQI) (at 12 weeks) · adults with insomnia
1 finding from 1 review
Adverse events (at 12 weeks) · adults with insomnia
1 finding from 1 review
PSG sleep outcomes (at 12 weeks) · adults with insomnia
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
It is very uncertain whether SSRIs changes failure to respond compared with benzodiazepines (very low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
It is very uncertain whether SSRIs changes total number of dropouts compared with benzodiazepines (very low certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
It is very uncertain whether SSRIs changes failure to remit compared with benzodiazepines (very low certainty).
1 finding from 1 review
panic symptoms · adults with panic disorder
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
It is very uncertain whether SSRIs changes number of dropouts due to adverse effects compared with benzodiazepines (very low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
SSRIs showed no clear difference in failure to respond compared with MAOIs (moderate certainty).
1 finding from 1 review